210 related articles for article (PubMed ID: 24570297)
21. Implementation of a medication therapy management collaborative within a pediatric health system.
Sneed G; Kappeler K; Gilmore T; Kuhn C
J Am Pharm Assoc (2003); 2018; 58(4S):S114-S119. PubMed ID: 29871801
[TBL] [Abstract][Full Text] [Related]
22. Effect of patient-led cooperative follow-up by general practitioners and community pharmacists on osteoporosis treatment persistence.
Poivret D; Goetz C; Zevering Y; Wilcke C; Noirez V
Int J Rheum Dis; 2021 Jul; 24(7):912-921. PubMed ID: 34058072
[TBL] [Abstract][Full Text] [Related]
23. Effectiveness of a medication-adherence tool: study protocol for a randomized controlled trial.
Hilbink M; Lacroix J; Bremer-van der Heiden L; van Halteren A; Teichert M; van Lieshout J
Trials; 2016 Jun; 17(1):274. PubMed ID: 27255080
[TBL] [Abstract][Full Text] [Related]
24. Addressing primary nonadherence: A collaboration between a community pharmacy and a large pediatric clinic.
Hackerson ML; Luder HR; Beck AF; Wedig JM; Heaton PC; Frede SM
J Am Pharm Assoc (2003); 2018; 58(4S):S101-S108.e1. PubMed ID: 29730152
[TBL] [Abstract][Full Text] [Related]
25. Summative service and stakeholder evaluation of an NHS-funded community Pharmacy Emergency Repeat Medication Supply Service (PERMSS).
Nazar H; Nazar Z; Simpson J; Yeung A; Whittlesea C
BMJ Open; 2016 Jan; 6(1):e009736. PubMed ID: 26787252
[TBL] [Abstract][Full Text] [Related]
26. Effectiveness of a Pharmacist-Led Web-Based Medication Adherence Tool With Patient-Centered Communication: Results of a Clustered Randomized Controlled Trial.
van Lieshout J; Lacroix J; van Halteren A; Teichert M
J Med Internet Res; 2022 Apr; 24(4):e16141. PubMed ID: 35389359
[TBL] [Abstract][Full Text] [Related]
27. The Innovative Canadian Pharmacogenomic Screening Initiative in Community Pharmacy (ICANPIC) study.
Papastergiou J; Tolios P; Li W; Li J
J Am Pharm Assoc (2003); 2017; 57(5):624-629. PubMed ID: 28689706
[TBL] [Abstract][Full Text] [Related]
28. The Medicines Advice Service Evaluation (MASE): a randomised controlled trial of a pharmacist-led telephone based intervention designed to improve medication adherence.
Lyons I; Barber N; Raynor DK; Wei L
BMJ Qual Saf; 2016 Oct; 25(10):759-69. PubMed ID: 26755665
[TBL] [Abstract][Full Text] [Related]
29. Impact of a community pharmacists' hypertension-care service on medication adherence. The AFenPA study.
Fikri-Benbrahim N; Faus MJ; Martínez-Martínez F; Sabater-Hernández D
Res Social Adm Pharm; 2013; 9(6):797-805. PubMed ID: 23391845
[TBL] [Abstract][Full Text] [Related]
30. Promoting transitions of care, safety, and medication adherence for patients taking fingolimod in community pharmacies.
Bourdin A; Schluep M; Bugnon O; Berger J
Am J Health Syst Pharm; 2019 Jul; 76(15):1150-1157. PubMed ID: 31201774
[TBL] [Abstract][Full Text] [Related]
31. Management of hypertension in an Australian community pharmacy setting - patients' beliefs and perspectives.
Bajorek BV; LeMay KS; Magin PJ; Roberts C; Krass I; Armour CL
Int J Pharm Pract; 2017 Aug; 25(4):263-273. PubMed ID: 27633151
[TBL] [Abstract][Full Text] [Related]
32. Complex pharmaceutical care intervention in pulmonary care: part A. The process and pharmacists' professional satisfaction.
Stuurman-Bieze AG; de Boer WO; Kokenberg ME; Hugtenburg JG; de Jong-van den Berg LT; Tromp TF
Pharm World Sci; 2005 Oct; 27(5):376-84. PubMed ID: 16341744
[TBL] [Abstract][Full Text] [Related]
33. TransitionRx: Impact of community pharmacy postdischarge medication therapy management on hospital readmission rate.
Luder HR; Frede SM; Kirby JA; Epplen K; Cavanaugh T; Martin-Boone JE; Conrad WF; Kuhlmann D; Heaton PC
J Am Pharm Assoc (2003); 2015; 55(3):246-54. PubMed ID: 26003155
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of a pilot study to influence medication adherence of patients with diabetes mellitus type-2 by the pharmacy.
Adhien P; van Dijk L; de Vegter M; Westein M; Nijpels G; Hugtenburg JG
Int J Clin Pharm; 2013 Dec; 35(6):1113-9. PubMed ID: 23942987
[TBL] [Abstract][Full Text] [Related]
35. Effect of medication review and cognitive behaviour treatment by community pharmacists of patients discharged from the hospital on drug related problems and compliance: design of a randomized controlled trial.
Ahmad A; Hugtenburg J; Welschen LM; Dekker JM; Nijpels G
BMC Public Health; 2010 Mar; 10():133. PubMed ID: 20230611
[TBL] [Abstract][Full Text] [Related]
36. Implementing a pharmacist-led in-home medication coaching service via community-based partnerships.
Akers JL; Meer G; Kintner J; Shields A; Dillon-Sumner L; Bacci JL
J Am Pharm Assoc (2003); 2019; 59(2):243-251. PubMed ID: 30638730
[TBL] [Abstract][Full Text] [Related]
37. Implementation of comprehensive medication management at supermarket pharmacies in a pharmacy network.
Doong K; Berenbrok LA; Coley KC; Carroll JC; Richardson R; Antinopoulos BC; Patel A; McGivney MS
J Am Pharm Assoc (2003); 2019; 59(4S):S25-S31. PubMed ID: 31080149
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of a mobile health intervention to support asthma self-management and adherence in the pharmacy.
Kosse RC; Bouvy ML; de Vries TW; Koster ES
Int J Clin Pharm; 2019 Apr; 41(2):452-459. PubMed ID: 31028598
[TBL] [Abstract][Full Text] [Related]
39. Closing the Gap: Identifying Rates and Reasons for Nonadherence in a Specialty Population.
Paolella D; Cherry E; Jolly JA; DeClercq J; Choi L; Zuckerman A
J Manag Care Spec Pharm; 2019 Nov; 25(11):1282-1288. PubMed ID: 31663457
[TBL] [Abstract][Full Text] [Related]
40. Regional osteoporosis screening, referral, and monitoring program in community pharmacies: findings from Project ImPACT: Osteoporosis.
Goode JV; Swiger K; Bluml BM
J Am Pharm Assoc (2003); 2004; 44(2):152-60. PubMed ID: 15098849
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
